Articles tagged with Eye Diseases
Researchers have discovered a new group of immune cells called NKRM cells that limit immune responses in tissues and prevent autoimmunity. This discovery may lead to new treatments for conditions like Sjogren's Syndrome and chronic inflammatory diseases.
A team of researchers discovered that a mutation in the HMGB1 protein causes a rare disorder with severe malformations, suggesting a link between protein droplets and genetic disease. The study's findings could have implications for understanding congenital malformations, common diseases, and cancer.
Researchers discover gene therapy ophNdi1 that boosts mitochondrial performance in retinal ganglion cells, potentially treating glaucoma and age-related macular degeneration. The therapy shows protective effects in three models of mitochondrial dysfunction.
Researchers at Virginia Tech aim to understand the role of fatty acid deficiency in optic nerve hypoplasia. A recent grant supports studies on arachidonic acid supplementation as a potential treatment for the disease.
Low blood sugar levels trigger an increase in retinal cell proteins, leading to overgrowth of abnormal blood vessels and worsening diabetic eye disease. The study suggests that keeping glucose levels stable is crucial for preventing vision loss in people with diabetes.
Researchers have created a technique that enables visualization of the retina and choroid with high resolution at distinct depths, revealing new insights into eye structure. The technology, called STOC-T, makes it possible to image all primary layers of the choroid for the first time.
Researchers have identified a new genetic risk factor for adult-onset macular degeneration by combining multiple maps. The study reveals that variations in the TRPM1 gene promoter alter LHX2 transcription factor binding, reducing gene activity and increasing disease risk. This finding advances our understanding of AMD's complex pathology.
Researcher Dana Hawley found that finches with mild and strong conjunctivitis symptoms spread a pathogen at higher rates than healthy birds. This suggests that pathogens can evolve to cause more harm to their hosts, leading to increased transmission.
A Canadian study reveals that obesity reprograms immune system cells, making them destructive to the eye as it ages. The research sheds light on the molecular mechanism behind AMD and may lead to tailored treatments in the future.
Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.
Researchers have successfully grown retinal cells from stem cells that can connect with neighboring cells and transmit sensory information like healthy ones. The breakthrough could lead to human clinical trials to treat degenerative eye disorders such as retinitis pigmentosa and age-related macular degeneration.
A mouse study found that proteins made by stem cells in mice with dry eye disease may be new targets for treating injuries to the cornea. The researchers identified a key gene, SPARC, that is activated in response to injury in dry eye disease and found higher levels of its protein are associated with better healing.
Scientists have created eye tissue using patient stem cells and 3D bioprinting, providing a model for studying the genesis of age-related macular degeneration. The printed tissue exhibited patterns of early AMD, including drusen deposits and progression to late dry stage AMD.
Researchers have identified a Vegf-Notch signaling system that enables Muller glial cells to regenerate retinal neurons in zebrafish. This discovery may help understand why the human retina does not regenerate and could inform treatments for blindness.
Scientists discover that visual cells in the human retina may be mechanically transported out of the retina before dying, leading to neurodegeneration. The discovery uses miniature human retinas grown in the laboratory and found that pharmacological agents can prevent extrusion.
Researchers explore the interactions between adipose tissues and surrounding blood vessels in connection with lipid metabolism and associated diseases. Targeting angiogenesis may provide a gateway for treating obesity, while its inhibition or promotion depends on the specific disease context.
Researchers have developed mini eyes, or organoids, from stem cells donated by patients with Usher syndrome. These mini eyes allow scientists to study light-sensing cells and understand the development of blindness in the disease.
Researchers identified five genetic variants that progressively increase the risk of becoming nearsighted with more schooling, especially for university-level education. These findings provide new insights into biological pathways causing nearsightedness and its interaction with lifestyle factors.
A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.
Regular use of cholesterol-lowering and diabetes-control drugs may lessen the risk of age-related macular degeneration (AMD) in European populations. The pooled data analysis involved 38,694 participants and showed a 15% lower prevalence of any type of AMD with these medications.
A large UK Biobank study found that poor quality sleep, including insomnia, short/long sleep duration, snoring, and daytime sleepiness, is associated with a heightened risk of developing glaucoma. The study suggests that targeted screening of high-risk groups and sleep intervention may help prevent the disease.
Scientists discovered the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE). The study suggests a therapeutic strategy for the disease, which currently lacks treatment.
Researchers found that increasing arginase 1 availability helps alleviate unhealthy responses and interrupt destructive inflammation in diabetic retinopathy and retinopathy of prematurity. This is achieved by reducing L-arginine levels, which in turn reduces inducible nitric oxide synthase activity.
NIH scientists mapped the organization of human retinal cell chromatin, revealing insights into regulation of gene expression and retinal function. The study identified distinct patterns of interaction at retinal genes suggesting how chromatin's 3D organization plays a crucial role in tissue-specific gene regulation.
Researchers developed an AI algorithm to assess retinal vasculature, predicting cardiovascular disease and death. The model captured half to two-thirds of circulatory disease deaths in those most at risk, outperforming traditional risk frameworks.
A new smartphone application, DryEyeRhythm, uses cameras to measure blink characteristics and administer questionnaires for diagnosing dry eye disease. The app has been validated in a study, showing high reliability and validity in assessing DED, with promising implications for early diagnosis and treatment.
Researchers at UCI have made significant progress in precision genome editing for treating inherited retinal diseases, enabling precise gene correction and disease rescue. The study highlights the potential of this technology to revolutionize treatment of genetic disorders of vision, with over 270 causative genes identified.
Researchers have developed a simplified and fast optoretinography approach to measure retinal function, potentially accelerating the development of new treatments for eye diseases. The technique can collect data from three healthy subjects in just ten minutes and has been demonstrated to be reproducible.
A recent study has found that people who wear reusable contact lenses are nearly four times as likely to develop a rare sight-threatening eye infection. The study identified multiple factors that increase the risk of Acanthamoeba keratitis, including reusing lenses or wearing them overnight or in the shower.
Claes H. Dohlman, considered the founder of modern cornea science, is honored with the prestigious Champalimaud Vision Award for his groundbreaking research on corneal physiology and its applications in treating dry eye disease, corneal burns, and keratoprosthesis.
A team of researchers from Japan successfully reconstructed common brain input signals from the firing rates of neurons using a method called superposed recurrence plot. This breakthrough has significant implications for artificial intelligence, neuroscience, and potential treatments for mental health disorders.
Researchers at the National Eye Institute used adaptive optics to visualize cells across different tissue layers in the eye, revealing dramatic enlargement of RPE cells in people with choroideremia. This discovery may help design effective treatments for this rare genetic disorder.
A new study from Aarhus University highlights the imbalance in AMD research using young male mice, despite the disease affecting the elderly. The review of 380 scientific articles emphasizes the need for better reporting and guidelines to improve animal testing quality.
Researchers from Trinity College Dublin have developed a new gene therapy approach targeting mitochondrial function to treat dry AMD, a debilitating eye disease. The therapy has shown benefit in multiple models of the condition, offering hope for a potential treatment that could help millions globally.
A new study has partly restored the function of retina's cone receptors in two completely colorblind children using gene therapy. The treatment has been shown to activate previously dormant communication pathways between the retina and brain, drawing on the plastic nature of the developing adolescent brain.
A study of over 26,000 eye care professionals found that those receiving small financial incentives from pharmaceutical companies are up to twice as likely to prescribe brand-name eyedrops for glaucoma. The researchers suggest that frequent exposure to positive messaging about a drug may influence this tendency.
A bioengineered cornea made from collagen protein can restore vision in people with diseased corneas, offering an alternative to donated human corneas. The implant has been shown to be safe and effective in a pilot study, with patients regaining perfect vision after two years.
Researchers at HKUMed & CityU discover that transcorneal electrical stimulation can alleviate depression-like symptoms and improve cognitive function in animal models. The technique also induced the expression of genes involved in brain cell growth, offering a potential new treatment for Alzheimer's disease.
Researchers at NIH have developed a 3D structure of the twinkle protein, which helps identify mutations that cause mitochondrial diseases. The discovery could lead to targeted treatments for patients with conditions like progressive external ophthalmoplegia and Perrault syndrome.
Researchers developed a non-invasive ocular imaging method to detect flavoprotein fluorescence in the eye, indicating mitochondrial oxidative stress. This technique may predict glaucoma progression earlier than current methods, with similar sensitivity to visual field changes.
The ISM Annual Meeting highlights new topics in oral, vaginal, skin, and gut microbiota, as well as their metabolites and potential implications in diseases like cancer, depression, and stroke. The meeting aims to explore the mechanism behind microbiota efficacy and its potential application in precision medicine.
Scientists reprogrammed stem cells to create models of diseased eye cells, analyzing DNA, RNA, and proteins to pinpoint genetic signatures. The study identified 439 molecular signatures associated with AMD, including potential new gene variants that target mitochondrial proteins.
Researchers have found correlations between retina and brain structures altered in Alzheimer's disease in healthy subjects at risk. These findings suggest the retina may provide information on brain state and changes, paving the way for new diagnostic tools.
A new study found that Black patients are six times more likely to have advanced vision loss after a glaucoma diagnosis, highlighting the need for early eye screening in this population. The research analyzed nearly 210,000 participants and used artificial intelligence to identify visual field loss patterns.
A recent study found that patients vividly remember the way they were told they had their condition, which affects their perception of vision loss and interactions with others. Clinicians should consider empathetic communication when delivering bad news to minimize long-term psychological impact.
A new study may help develop therapies to slow vision loss in pigmentary retinopathy by understanding how the visual system adapts to photoreceptor death. The research found that the visual pathway becomes hyperactive during early RP, which could lead to therapeutic protection and restoration of vision.
Researchers developed a nanomembrane system called iTEARS that can quickly analyze tears for disease biomarkers. The system enables more efficient and less invasive molecular diagnoses for various diseases, including dry eye disease and diabetic retinopathy.
Researchers at Cornell University found connections between the brain's olfactory pathway and visual cortex in dogs, showing that olfaction is integrated with vision in terms of learning about the environment. This study corroborates clinical experiences with blind dogs who function remarkably well despite their condition.
Research from the University of Georgia suggests that a diet rich in bright-colored fruits and vegetables, particularly those high in lutein and zeaxanthin, can help prevent visual and cognitive loss in women. This is due to the antioxidant properties of these carotenoids, which have been shown to improve central nervous system degener...
Children born to mothers with polycystic ovary syndrome (PCOS) are at a higher risk of developing infections, allergies, and other childhood illnesses by age 13. The study found that children of mothers with PCOS were 32% more likely to be admitted to hospital for various health problems.
A low-cost device can capture 3D images of the retina, cornea, and back of the eye, revolutionizing eye screening and treatment globally. The technology has the potential to detect eye diseases like glaucoma and improve patient care.
Researchers identified Srrm3 as a master regulator gene for photoreceptor cells in the retina, which is critical for visual function. The study found that misregulation of alternative splicing and microexons can lead to devastating health impacts, including vision loss.
A study found that patients with a specific form of age-related macular degeneration are at significant risk for cardiovascular disease and stroke. Researchers discovered a strong association between the disorder's subretinal drusenoid deposits and high-risk vascular diseases.
The new human cell line, ABC, was developed from retinal pigment epithelial cells and retains their properties, allowing for the study of events relevant to normal repair processes. The research may lead to discoveries in senescence gene programming, neuroprotection, and cellular replacement therapies for blinding eye diseases
Researchers at A*STAR's Institute of Molecular and Cell Biology developed a bio-functional thermogel that prevents retinal scarring in pre-clinical models. The thermogel modulates cellular behavior to prevent scar membrane formation, offering a novel therapy for proliferative vitreoretinopathy.
Researchers found a protein in eye fluid linked to disease progression in patients with wet age-related macular degeneration. Measuring its levels can accurately predict treatment needs, allowing for safe reduction or cessation of therapies.
A new deep learning model can accurately identify disease-related features from images of eyes, even in low-quality images. The lightweight model is deployable on mobile devices and has better segmentation accuracy than other commercial software.
Chronic kidney disease and glaucoma have been found to share common risk factors such as diabetes and hypertension, leading to a higher risk of developing both conditions. The study also reveals that patients with glaucoma are more likely to develop chronic kidney disease over time.
Researchers found that retinal cells are more susceptible to Ebola virus infection than iris cells, which could lead to uveitis diagnosis and treatment. This discovery highlights the importance of monitoring retinal cells during acute viral infections to identify patients at high risk.
A team from UNIGE has identified a molecular mechanism that causes degeneration of photoreceptors in retinitis pigmentosa, a genetic disease leading to blindness. The discovery could lead to therapeutic treatments targeting this mechanism.